英为财情Investing.com - Hyperfine (NASDAQ: HYPR )星期二发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益符合分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.140，总营收为$3.64M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$3.3M，每股收益为$-0.140.

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared ...

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago. These figures are adjusted for ...

Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ETCompany ParticipantsMarissa Bych - Gilmartin GroupMaria Sainz ...

Hyperfine Inc (NASDAQ:HYPR) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 ...

康涅狄格州吉尔福德 - 医疗技术先驱Hyperfine, Inc. (NASDAQ:HYPR)宣布其最新的Swoop®系统软件获得CE认证。根据欧洲医疗器械法规获得的这一认证是该公司在欧洲扩张的关键一步，使其便携式磁共振 (MR)脑成像系统能够更广泛地商业化推广。

Hyperfine secured initial CE certification for the Swoop ® system in 2023. Earlier this year, Hyperfine significantly ...

Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients ...

Hyperfine (HYPR) announced CE approval of its latest generation of AI-powered Swoop system software under the European Medical Device ...

Today’s presentation at CTAD, a leading international Alzheimer's conference, expands research supporting the value of ultra-low-field MRI in monitoring amyloid-related imaging abnormalities (ARIA).

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...